Dec 3, 2007 - MolMed appointed Dr. Daniele Pieraccioli as Director of Intellectual Property   


Oct 30, 2007 - MolMed sponsor of ESGCT Young Investigator Award in memory of Salvatore Toma   
ESGCT Young Investigator Award (YIA) 2007: MolMed sponsored one of the three YIA of the European Society of Gene and cell Therapy (ESGCT), and delivered the award to the winner during the ESGCT Congress Presidential Symposium on October 30, 2007.

MolMed will be permanent sponsor of a ESGT Young Investigator Award, devoted to the memory of Salvatore Toma.


Oct 23, 2007 - MolMed presented a poster at the AACR-NCI-EORTC Conference “Molecular Targets and Cancer Therapeutics”   MolMed presented a poster on Tuesday, October 23, within Session A: "Antiangiogenic/Antivascular Agents". Abstract A20, title: "Structural basis for L-isoDGR stereospecific recognition of αvβ3".


Jun 2, 2007 - ARENEGYR Phase I clinical trial results presented at ASCO 2007   Results of ARENEGYR Phase I trial NGR002 presented at ASCO 2007 within the Section "Developmental Therapeutics/Molecular Therapeutics".

Poster Number 11, Abstract Number 3540, Title:"Safety and anticancer activity of low dose regimen of NGRhTNF, a new vascular targeting agent, in solid advanced malignancies (NGR002 phase I trial)".

ARCHIVE

| 2010 | 2009 | 2008 | 2007 |